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 Although  the  21
st century has seen significant changes in 
health care reforms and practices, and has experienced quick 
progression in the understanding of infectious diseases, 
diarrhea caused by enteric infections is a major factor in 
morbidity and mortality worldwide and it is estimated 2-4 
billion episodes of infectious diarrhea occur each year and are 
especially prevalent in infants. Further, diarrhea as well as 
other infections associated with different pathogenic 
Escherichia coli strains continue to be a health problem in 
some tropical and subtropical areas and are one of the leading 
causes of disease and death in humans and animals [1]. In 
Latin America, infectious disease research, as well as basic 
and applied science in general, is receiving significant atten- 
tion, despite many challenges that the scientific community 
are still facing in this region. In response to the significant 
increase in the number of scientific papers published by Latin 
American authors, governments (particularly those of Brazil, 
Argentina, Chile, and Mexico) have announced packages and 
incentives to foster science and technology [2]. 
  A good example from incentives that have begun to 
deliver results are those made by the Brazilian government 
which in the past 15 years have increased the number of 
graduate school programs, support research centers of 
excellence, and to establish and to consolidate a national 
system for science, technology and innovation [2]. Apart 
from the country's estimated 7.5% economic growth in 2010, 
efforts continue for the consolidation and expansion of 
research at traditional Universities and Institutes, allowing 
the investigators to partner with private investors and/or 
companies, advancing Research and Development [3], while 
promoting science and technology to Society. 
  The significant scientific advances currently happening 
in different Brazilian laboratories is represented in this mini  
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hot topic issue entitled “Recent advances in the study of 
pathogenic Escherichia coli in Brazil”. The issue highlights 
the diversity of research topics in the E. coli field currently 
explored in this country; including the identification of 
potentially virulent E. coli strains in parrots and parakeets; 
the discovery that different avian pathogenic E. coli 
subgroups are associated to a specific infectious syndrome in 
poultry; the characterization of different phenotypic 
characteristics of human pathogenic E. coli strains; and the 
importance of Shiga toxin-producing E. coli O157 as agents 
of Hemolytic Uremic Syndrome in Brazilian patients.  
  The highlighted research papers in this issue are part of a 
largest effort in Latin America by the pathogenic E. coli 
scientific community to foster long-standing continent-wide 
collaborations for the promotion and dissemination of their 
research and to educate and prepare the next generation of 
Latin American E. coli investigators. In response to this 
effort, the Latin American Coalition for Escherichia coli 
Research (LACER) was created, consisting of a multi- 
disciplinary network of more than 60 international research 
groups working on pathogenic E. coli, with the ultimate goal 
of advancing our understanding and disseminating the E. coli 
research in this region. One of the fist accomplishments of 
LACER was the publication of an e-book that contains a 
comprehensive analysis of the most common categories of  
E. coli associated with diarrheal illness in Latin America   
[1]. As a second major effort to disseminate the research 
performed in specific laboratories in the region, the mini- 
hot topic issue in The Open Microbiology Journal became  
a reality. 
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